About
BioConscious Technologies Inc develops an AI-driven predictive metabolic platform called Endobits, which analyzes continuous glucose monitoring data to forecast glucose levels and classify metabolic phenotypes for early detection and prevention of diabetes and related metabolic diseases.
Explore BioConscious Technologies Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.